The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November ...

Renal denervation; RSDforAF: Renal sympathetic denervation for AF. 1 Pole de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain ...

Interv Cardiol. 2014;6(1):57-69.

Against this backdrop, catheter-based renal denervation (RDN) has emerged as a novel interventional strategy for the management of treatment-resistant hypertension. RDN involves the selective ...

Over-activation of the sympathetic nervous system has been implicated in the initiation and progression of both hypertension and kidney disease. Renal denervation is an emerging treatment for both ...

Second, the AoCo model might be accompanied by elevated arterial carotid and aortic baroreceptor activation which might suppress the normal vasomotor and renal sympathetic tone ... and renal ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension.

U.S. Medicare coverage of renal denervation (RDN) for uncontrolled hypertension may soon be a fact of life if the manufacturers of these systems have their way. CMS opened a national coverage analysis ...

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

Medtronic (NYSE:MDT) said the U.S. Centers for Medicare & Medicaid Services is opening a coverage analysis on renal ...